COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,962 Articles (22,604 medRxiv, 8,358 bioRxiv)

Most recent first Previous |  Page 2393: Articles 23921-23930  | Next

SARS-CoV-2 in-vitro neutralization assay reveals inhibition of virus entry by iota-carrageenan
Morokutti-Kurz, M., Graf, P., Grassauer, A., Prieschl-Grassauer, E.
10.1101/2020.07.28.224733 — Posted: 2020-07-28 Discussion: Onsite | Offsite
A Speedy Route to Multiple Highly Potent SARS-CoV-2 Main Protease Inhibitors
Liu, W. R., Yang, K. S., Ma, X. R., Ma, Y., Alugubelli, Y. R., Scott, D. A., Vatansever, E. C., Drelich, A. K., Geng, Z. Z., Blankenship, L. R., Sankaran, B., Ward, H. E., Sheng, Y. J., Hsu, J. C., Kratch, K. K., Zhao, B., Liu, J., Li, P., Fierke, C. A., Tseng, C.-T. K., Xu, S., Hayatshahi, H. S.
10.1101/2020.07.28.223784 — Posted: 2020-07-28
Pyronaridine and artesunate are potential antiviral drugs against COVID-19 and influenza
Bae, J.-Y., Lee, G. E., Park, H., Cho, J., Kim, Y.-E., Lee, J.-Y., Ju, C., Kim, W.-K., Kim, J. I., Park, M.-S.
10.1101/2020.07.28.225102 — Posted: 2020-07-28
Antibodies that potently inhibit or enhance SARS-CoV-2 spike protein-ACE2 interaction isolated from synthetic single-chain antibody libraries
Beasley, M. D., Aracic, S., Gracey, F. M., Kannan, R., Masarati, A., Premaratne, S. R., Udawela, M., Wood, R. E., Jabar, S., Church, N., Le, T.-K., Makris, D., McColl, B. K., Kiefel, B. R.
10.1101/2020.07.27.224089 — Posted: 2020-07-28
Mononeuritis multiplex: an unexpectedly common feature of severe COVID-19
Needham, E., Newcombe, V., Michell, A., Thornton, R., Grainger, A., Anwar, F., Warburton, E., Menon, D., Trivedi, M., Sawcer, S.
10.1101/2020.07.19.20149898 — Posted: 2020-07-28
Association of olfactory dysfunction with hospitalization for COVID-19: a multicenter study in Kurdistan
Zobairy, H., Shamsoddin, E., Rasouli, M. A., Veisi Khodlan, N., Moradi, G., Zareie, B., Teymori, S., Asadi, J., Sofi-Mahmudi, A., Sedaghat, A. R.
10.1101/2020.07.26.20158550 — Posted: 2020-07-28
Impact of climatic parameters on COVID-19 pandemic progression in India: analysis and prediction
Deyal, N., Tiwari, V., Bisht, N.
10.1101/2020.07.25.20161919 — Posted: 2020-07-28
Social Listening: A Thematic Analysis of COVID-19 Discussion on Social Media
Afolabi, D. S. A., Folorunso, S. O., Bunyula, Z. S., Banjo, O. O., Matshika, S. S., Warrie, W. U., Ngqambela, N., Adepoju, A. E., Rabophala, H., Abimbola, O. V., Olanipekun, M. S., Odukoya, A. L.
10.1101/2020.07.25.20162040 — Posted: 2020-07-28
Longitudinal COVID-19 Surveillance and Characterization in the Workplace with Public Health and Diagnostic Endpoints
Gunawardana, M., Breslin, J., Cortez, J. M., Rivera, S., Webster, S., Ibarrondo, F. J., Yang, O. O., Pyles, R. B., Ramirez, C. M., Adler, A. P., Anton, P. A., Baum, M. M.
10.1101/2020.07.25.20160812 — Posted: 2020-07-28
Changes in Cause-of-Death Attribution During the Covid-19 Pandemic: Association with Hospital Quality Metrics and Implications for Future Research
Fairman, K. A., Goodlet, K. J., Rucker, J. D.
10.1101/2020.07.25.20162198 — Posted: 2020-07-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).